Contrarian Opportunities in Biotech Venture Forbes Heart failure. Despite its massive cost on the healthcare system, a number of Pharma with legacy franchises in heart failure have deprioritized their efforts over the past few years, at least temporarily, including long-time heart failure leader Pfizer ... |
